Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two Approaches to Escalate Lispro Therapy in Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin and Oral Agents
2010-021516-42Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Started Oct 2010; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-021516-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021516-42.